These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1240 related items for PubMed ID: 15086153

  • 1. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H.
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [Abstract] [Full Text] [Related]

  • 2. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M, Kato M, Sugiyama T, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S, Japan Helicobacter pylori Eradication Study Group.
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [Abstract] [Full Text] [Related]

  • 3. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T, Kanoh Y, Higuchi K, Arakawa T, Morisita T.
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [Abstract] [Full Text] [Related]

  • 4. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ, Lee DH, Kim N, Jung SH, Kim JW, Hwang JH, Park YS, Lee KH, Jung HC, Song IS.
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [Abstract] [Full Text] [Related]

  • 5. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C, Triantafyllou K, Mallas E, Triantafyllou G, Ladas SD.
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.
    Mitrică D, Pleşa A, Constantinescu R, Drug V, Stanciu C.
    Rev Med Chir Soc Med Nat Iasi; 2011 Jul; 115(2):367-74. PubMed ID: 21870725
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
    Santander C, Grávalos RG, Gómez-Cedenilla A, Cantero J, Pajares JM.
    Am J Gastroenterol; 1996 Aug; 91(8):1549-52. PubMed ID: 8759659
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy of quadruple therapy in the eradication of Helicobacter pylori and prevention of recurrent duodenal ulcer].
    Ocaña Andrade E, Espinosa Soberanes JA, Mares Zambrano MA, Rosete Reyes A.
    Rev Gastroenterol Mex; 1998 Aug; 63(4):182-6. PubMed ID: 10319667
    [Abstract] [Full Text] [Related]

  • 9. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence.
    Parente F, Bargiggia S, Bollani S, Colombo E, Bianchi Porro G.
    Hepatogastroenterology; 1998 Aug; 45(22):990-3. PubMed ID: 9755995
    [Abstract] [Full Text] [Related]

  • 10. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC, Lee CL, Chan CC, Tu TC, Liao CC, Wu CH, Chen TK.
    Arch Intern Med; 2003 Sep 22; 163(17):2020-4. PubMed ID: 14504114
    [Abstract] [Full Text] [Related]

  • 11. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S, Keleş H, Ozkurt ZN, Cengiz DU, Kolukisa E.
    Turk J Gastroenterol; 2005 Mar 22; 16(1):29-33. PubMed ID: 16252185
    [Abstract] [Full Text] [Related]

  • 12. Causal role of Helicobacter pylori in peptic ulcer relapse.
    Asaka M, Ohtaki T, Kato M, Kudo M, Kimura T, Meguro T, Horita S, Inoue K.
    J Gastroenterol; 1994 Jul 22; 29 Suppl 7():134-8. PubMed ID: 7921146
    [Abstract] [Full Text] [Related]

  • 13. Relapse of duodenal ulcers after successful eradication of Helicobacter pylori in gastric ulcer patients.
    Sou Y, Saita H, Takahashi Y, Yoshinaga T, Matsukawa Y, Sekikawa A, Nakazawa T, Shio S, Kohigashi K.
    J Gastroenterol; 1999 Jul 22; 34 Suppl 11():84-90. PubMed ID: 10616773
    [Abstract] [Full Text] [Related]

  • 14. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov 22; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 15. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
    Labenz J, Börsch G.
    Am J Gastroenterol; 1994 Oct 22; 89(10):1785-8. PubMed ID: 7942667
    [Abstract] [Full Text] [Related]

  • 16. [A comparative study; one week treatment versus two weeks treatment with lansoprazol, amoxycillin and clarythromycin for the eradication of Helicobacter pylori in patient with gastric and duodenal ulcer].
    Nakagawa M, Ooishi M, Yoda Y, Kawamura N, Ooizumi H, Saitou M, Nakagawa S.
    Nihon Rinsho; 1999 Jan 22; 57(1):144-7. PubMed ID: 10036952
    [Abstract] [Full Text] [Related]

  • 17. One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing.
    Hsu CC, Lu SN, Changchien CS.
    Hepatogastroenterology; 2003 Jan 22; 50(53):1731-4. PubMed ID: 14571829
    [Abstract] [Full Text] [Related]

  • 18. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR, Haber MM, Sheldon E, Collis C, Lukasik N, Huang B, Goldstein JL.
    Am J Gastroenterol; 2002 Sep 22; 97(9):2208-14. PubMed ID: 12358234
    [Abstract] [Full Text] [Related]

  • 19. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Vergara M, Catalán M, Gisbert JP, Calvet X.
    Aliment Pharmacol Ther; 2005 Jun 15; 21(12):1411-8. PubMed ID: 15948807
    [Abstract] [Full Text] [Related]

  • 20. Short-term eradication therapy for Helicobacter pylori does not reduce the incidence of gastric metaplasia in duodenal ulcer patients.
    Rudnicka L, Bobrzyński A, Stachura J.
    Pol J Pathol; 1997 Jun 15; 48(2):103-6. PubMed ID: 9278106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.